A review of therapeutic agents for breast cancer with potentially radiosensitizing properties  

作　　者：Zhongwei Zhang David Lim Zhihui Feng 

机构地区：[1]Department of Occupational Health and Occupational Medicine,School of Public Health,Cheeloo College of Medicine,Shandong University,Jinan 250012,China [2]Centre for Improving Palliative,Aged and Chronic Care Through Clinical Research and Translation,Faculty of Health,University of Technology Sydney,NSW,2007,Australia

出　　处：《Radiation Medicine and Protection》2024年第2期75-82,共8页放射医学与防护（英文）

基　　金：National Natural Science Foundation of China,China(No.82173460,82373518).

摘　　要：Breast cancer is the most frequently diagnosed malignant tumor in women worldwide and the leading cause of cancer death.Radiotherapy for breast cancer is readily accepted and widely used in clinical practice.Potential limitations with radiotherapy include treatment resistance,side effects,and complications caused by high doses of irradiation.The search has been on to locate an efficacious radiosensitizer.This review summarizes six currently approved pharmaceuticals that have also been investigated for off-label use as radiosensitizers in breast cancer.

关 键 词：Breast cancer RADIOTHERAPY RADIOSENSITIZER Therapeutic agents 

分 类 号：R730.5[医药卫生—肿瘤]